Drug classes with largest print ad spend in the U.S. 2020
In a ranking of leading drug classes in the United States, based on professional health print journals ad spend between January and June 2020, antineoplastic agents ranked first, with 39.2 million U.S. dollars invested in professional print journals ad spend in the presented period.
